← Back to Search

LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers

Phase 2
Recruiting
Research Sponsored by Hearthstone Alzheimer Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment--that is during week 23 thru week 24.
Awards & highlights
No Placebo-Only Group

Summary

This trial involves the LEAD IT! app, a tablet-based application designed to help people with early-stage dementia lead group activities for their peers. The target population is individuals with early-stage dementia living in long-term care facilities. The app aims to provide these individuals with a sense of purpose and improve their engagement by enabling them to guide structured activities.

Eligible Conditions
  • Alzheimer's Disease
  • Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment--that is during week 23 thru week 24.
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment--that is during week 23 thru week 24. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dementia Related Quality of Life
Dementia Related Quality of Life (DEMQOL)
Menorah Park Engagement Scale
Secondary study objectives
Cohen Mansfield Agitation Inventory
Geriatric Depression Scale-Short Form
Neuropsychiatric Inventory-Nursing Home

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental, LEAD IT! ProgrammingExperimental Treatment1 Intervention
Participants in the Experimental / LEAD IT! arm will take part in LEAD IT! programming for 18 weeks. The programming will occur twice per week, for a total of 36 sessions.
Group II: Control, Standard Care / ProgrammingActive Control1 Intervention
Participants in the Control arm will receive standard care / programming.

Find a Location

Who is running the clinical trial?

Hearthstone Alzheimer CareLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
~35 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top